BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 2458177)

  • 1. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
    Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
    CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
    Gill PS
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
    Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma.
    Tavio M; Vaccher E; Antinori A; Ammassari A; Cusini M; Fasan M; Accurso V; Garavelli LP; Repetto L; Tirelli U
    Cancer; 1996 May; 77(10):2117-22. PubMed ID: 8640679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon alpha 2C in the treatment of 2 patients with AIDS-associated Kaposi sarcoma].
    Steger G; Dittrich C; Eichler HG; Flener R; Moser K
    Wien Klin Wochenschr; 1987 Feb; 99(4):120-3. PubMed ID: 3577187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and beta-interferon: results of a phase 2 study.
    Krigel RL; Padavic-Shaller KA; Rudolph AR; Poiesz BJ; Comis RL
    J Biol Response Mod; 1989 Aug; 8(4):359-65. PubMed ID: 2666585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: a prospective evaluation using an endoscopic method of disease quantification.
    Laine L; Amerian J; Rarick M; Harb M; Gill PS
    Am J Gastroenterol; 1990 Aug; 85(8):959-61. PubMed ID: 1695812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome.
    Gelmann EP; Longo D; Lane HC; Fauci AS; Masur H; Wesley M; Preble OT; Jacob J; Steis R
    Am J Med; 1987 Mar; 82(3):456-62. PubMed ID: 2435150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's phenomenon and digital gangrene as a consequence of treatment for Kaposi's sarcoma.
    Hladunewich M; Sawka C; Fam A; Franssen E
    J Rheumatol; 1997 Dec; 24(12):2371-5. PubMed ID: 9415644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
    Amantea MA; Forrest A; Northfelt DW; Mamelok R
    Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic trial of interferon-gamma in patients with epidemic Kaposi's sarcoma.
    Krigel RL; Odajnyk CM; Laubenstein LJ; Ostreicher R; Wernz J; Vilcek J; Rubinstein P; Friedman-Kien AE
    J Biol Response Mod; 1985 Aug; 4(4):358-64. PubMed ID: 3928825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor.
    Mastroianni A; Coronado O; Cancellieri C; Manfredi R; Pignatari S; Chiodo F
    J Chemother; 1998 Oct; 10(5):405-10. PubMed ID: 9822360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma and AIDS: a variable spectrum.
    Shepherd FA; Hogg-Johnson S; Fleshner N; Read SE; Fanning MM; Johnson K; Goss P; Coates RA
    Clin Invest Med; 1989 Dec; 12(6):367-73. PubMed ID: 2612089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AIDS-associated Kaposi's sarcoma: 22 cases].
    Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
    Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced, progressive epidemic Kaposi's sarcoma (EKS): a phase-II study.
    Mitrou PS; Fischer C; Huhn D; Rasokat H; Ring J; Bergmann L
    Onkologie; 1988 Feb; 11(1):61-2. PubMed ID: 2452394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
    Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
    Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
    AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
    Zidan J; Robenstein W; Abzah A; Taman S
    Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected toxicity from radiation therapy in two patients with Kaposi's sarcoma receiving interferon.
    Real FX; Krown SE; Nisce LZ; Oettgen HF
    J Biol Response Mod; 1985 Apr; 4(2):141-6. PubMed ID: 3998765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.